A narrative review of meal management with the MiniMed ™ 780G system: Evolution of dietary management in type 1 diabetes
Fuente:
Wiley Open Access
Salvato in:
| Autori principali: | Shannon Edd, Maya Laron‐Hirsch, Javier Castañeda, Tim van den Heuvel, Goran Petrovski, Ohad Cohen |
|---|---|
| Natura: | Artículo Open Access |
| Pubblicazione: |
Wiley
2025
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Documenti analoghi
Challenges in glycaemic control among women with type 1 diabetes and the role of MiniMed 780G system: A narrative review
di: Isabeau Thijs, et al.
Pubblicazione: (2026)
di: Isabeau Thijs, et al.
Pubblicazione: (2026)
Predictors of glycaemic improvement in children and young adults with type 1 diabetes and very elevated HbA1c using the MiniMed 780G system
di: Yongwen Zhou, et al.
Pubblicazione: (2025)
di: Yongwen Zhou, et al.
Pubblicazione: (2025)
Performance of the MiniMed 780 G system on mitigating menstrual cycle‐dependent glycaemic variability
di: Yasmine Ibrahim Elhenawy, et al.
Pubblicazione: (2024)
di: Yasmine Ibrahim Elhenawy, et al.
Pubblicazione: (2024)
Generating real‐world evidence on diabetes technology using the CareLink Personal data management system
di: Tim van den Heuvel, et al.
Pubblicazione: (2024)
di: Tim van den Heuvel, et al.
Pubblicazione: (2024)
Discordant real‐world glycaemic outcomes with Omnipod™ 5 and MiniMed™ 780G in adults with type 1 diabetes: Why validated measures matter
di: Panagiotis Pavlou, et al.
Pubblicazione: (2026)
di: Panagiotis Pavlou, et al.
Pubblicazione: (2026)
Is low‐dose glucagon needed and effective in preventing fasted exercise‐induced hypoglycaemia in type 1 diabetes treated with the MiniMed 780G , an automated insulin delivery system?
di: Sissel Banner Lundemose, et al.
Pubblicazione: (2024)
di: Sissel Banner Lundemose, et al.
Pubblicazione: (2024)
Comment to ‘Minimum expectations for market authorization of continuous glucose monitoring devices in Europe—“ eCGM ”’
di: Ohad Cohen, et al.
Pubblicazione: (2025)
di: Ohad Cohen, et al.
Pubblicazione: (2025)
What is the impact of an advanced hybrid closed‐loop system on weight control among people with type 1 diabetes?
di: Sarah Koning, et al.
Pubblicazione: (2025)
di: Sarah Koning, et al.
Pubblicazione: (2025)
Striving for early effective glycaemic and weight management in type 2 diabetes: A narrative review
di: Alice Y. Y. Cheng, et al.
Pubblicazione: (2025)
di: Alice Y. Y. Cheng, et al.
Pubblicazione: (2025)
The role of real‐time continuous glucose monitoring in diabetes management and how it should link to integrated personalized diabetes management
di: Monika Reddy, et al.
Pubblicazione: (2024)
di: Monika Reddy, et al.
Pubblicazione: (2024)
Practical strategies to manage obesity in type 2 diabetes
di: Helena W. Rodbard, et al.
Pubblicazione: (2024)
di: Helena W. Rodbard, et al.
Pubblicazione: (2024)
Impact of an online nutrition management application service on glycaemic management in individuals with diabetes: A propensity‐score‐matched retrospective cohort study
di: Junya Hironaka, et al.
Pubblicazione: (2024)
di: Junya Hironaka, et al.
Pubblicazione: (2024)
Economic burden of type 2 diabetes management in France according to clinical characteristics
di: Bruno Guerci, et al.
Pubblicazione: (2026)
di: Bruno Guerci, et al.
Pubblicazione: (2026)
Beyond glycated haemoglobin: Modelling contemporary management of type 2 diabetes with the updated Cardiff model
di: Phil McEwan, et al.
Pubblicazione: (2025)
di: Phil McEwan, et al.
Pubblicazione: (2025)
Association between diabetes self‐management education attendance, hospital admissions and mortality in type 2 diabetes: A cohort analysis protocol
di: Gemma A. Lewis, et al.
Pubblicazione: (2025)
di: Gemma A. Lewis, et al.
Pubblicazione: (2025)
A systematic review of glucocorticoid use in type 1 diabetes: Glycaemic effects and clinical management strategies
di: Alexandra Katz, et al.
Pubblicazione: (2026)
di: Alexandra Katz, et al.
Pubblicazione: (2026)
Association between daily steps, diabetes management and health indicators in people living with type 1 diabetes: A cross‐sectional study from the BETTER registry
di: Thélo I. Garré, et al.
Pubblicazione: (2026)
di: Thélo I. Garré, et al.
Pubblicazione: (2026)
Oral or injectable semaglutide for the management of type 2 diabetes in routine care: A multicentre observational study comparing matched cohorts
di: Gian Paolo Fadini, et al.
Pubblicazione: (2024)
di: Gian Paolo Fadini, et al.
Pubblicazione: (2024)
An overview of the CANVAS Program and CREDENCE trial: The primary outcomes and key clinical implications for those managing patients with type 2 diabetes
di: Angela X. Chen, et al.
Pubblicazione: (2024)
di: Angela X. Chen, et al.
Pubblicazione: (2024)
Metformin monotherapy versus predominantly older non‐metformin antidiabetic medications for cerebrovascular risk in early type 2 diabetes management
di: Mingyang Sun, et al.
Pubblicazione: (2024)
di: Mingyang Sun, et al.
Pubblicazione: (2024)
Effectiveness of oral semaglutide versus empagliflozin for the management of type 2 diabetes. PIONEER ‐2 trial emulation with real‐world data
di: Gian Paolo Fadini, et al.
Pubblicazione: (2025)
di: Gian Paolo Fadini, et al.
Pubblicazione: (2025)
Predictors of diabetic ketoacidosis in patients with insulin‐deficient diabetes phenotype initiating SGLT2 inhibitors
di: Anat Tsur, et al.
Pubblicazione: (2025)
di: Anat Tsur, et al.
Pubblicazione: (2025)
Longitudinal trajectories of fasting plasma glucose predicting cardiovascular disease risk in Chinese patients with type 2 diabetes under health management
di: Shijun Liu, et al.
Pubblicazione: (2025)
di: Shijun Liu, et al.
Pubblicazione: (2025)
A predictive model for medium‐term weight loss response in people with type 2 diabetes engaging in behavioural weight management interventions
di: Lulwa Al‐Abdullah, et al.
Pubblicazione: (2024)
di: Lulwa Al‐Abdullah, et al.
Pubblicazione: (2024)
Potential benefits of hybrid closed‐loop systems for managing moderate‐ to high‐risk individuals with type 1 diabetes during Ramadan fasting
di: Abdullah M. Alguwaihes, et al.
Pubblicazione: (2025)
di: Abdullah M. Alguwaihes, et al.
Pubblicazione: (2025)
Early subcutaneous basal insulin with intravenous insulin infusion for diabetic ketoacidosis management: A systematic review and meta‐analysis of randomised controlled trials
di: Kitti Thammakosol, et al.
Pubblicazione: (2025)
di: Kitti Thammakosol, et al.
Pubblicazione: (2025)
Comparable glycemic outcomes with insulin glargine and insulin degludec during exercise in adolescents with type 1 diabetes using a standardized management protocol
di: Ivana Rabbone, et al.
Pubblicazione: (2025)
di: Ivana Rabbone, et al.
Pubblicazione: (2025)
Use of continuous glucose monitoring when initiating glucagon‐like peptide ‐ 1 receptor agonist therapy in insulin‐treated diabetes
di: Irl B. Hirsch, et al.
Pubblicazione: (2024)
di: Irl B. Hirsch, et al.
Pubblicazione: (2024)
Correction to ‘Early subcutaneous basal insulin with intravenous insulin infusion for diabetic ketoacidosis management: A systematic review and meta‐analysis of randomised controlled trials’
Pubblicazione: (2026)
Pubblicazione: (2026)
Partial non‐adherence to antidiabetic therapy undermines diabetes management and correlates with treatment complexity: A cross‐sectional study using blood plasma analysis
di: Vojtěch Škop, et al.
Pubblicazione: (2025)
di: Vojtěch Škop, et al.
Pubblicazione: (2025)
Real‐world effectiveness of sodium‐glucose cotransporter‐2 inhibitors on the progression of chronic kidney disease in patients without diabetes, with and without albuminuria
di: Afif Nakhleh, et al.
Pubblicazione: (2024)
di: Afif Nakhleh, et al.
Pubblicazione: (2024)
The challenge of assessing impaired awareness of hypoglycaemia in diabetes in the era of continuous glucose monitoring: A narrative review of evidence and translation into clinical practice
di: Simon A. Berry, et al.
Pubblicazione: (2025)
di: Simon A. Berry, et al.
Pubblicazione: (2025)
Trends in pharmacological management of paediatric patients with type 2 diabetes from 2000 to 2023 in German‐speaking countries: Analysis based on the Diabetes Prospective Follow‐up Registry
di: Susanna Wiegand, et al.
Pubblicazione: (2024)
di: Susanna Wiegand, et al.
Pubblicazione: (2024)
Comment on “Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes”
di: Manish R. Bhise, et al.
Pubblicazione: (2025)
di: Manish R. Bhise, et al.
Pubblicazione: (2025)
Cost–utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy—An Italian healthcare system perspective
di: Stefano Del Prato, et al.
Pubblicazione: (2024)
di: Stefano Del Prato, et al.
Pubblicazione: (2024)
Impact of continuous glucose monitoring on hospitalizations and glucose control in people with type 2 diabetes: real‐world analysis
di: Satish K. Garg, et al.
Pubblicazione: (2024)
di: Satish K. Garg, et al.
Pubblicazione: (2024)
Optimising the CamAPS FX automated insulin delivery system for exercise and complex meals in adolescents with type 1 diabetes: A prospective interventional study in a camp setting
di: Andrea E. Scaramuzza, et al.
Pubblicazione: (2025)
di: Andrea E. Scaramuzza, et al.
Pubblicazione: (2025)
The melanocortin‐4 receptor pathway and the emergence of precision medicine in obesity management
di: Sima Fansa, et al.
Pubblicazione: (2024)
di: Sima Fansa, et al.
Pubblicazione: (2024)
The Goldilocks for chronic weight management—Balancing quantity with quality of weight loss
di: Kim Henriksen, et al.
Pubblicazione: (2025)
di: Kim Henriksen, et al.
Pubblicazione: (2025)
Spillover effects of a nudge‐based dietary intervention on physical activity and sleep among adults with type 2 diabetes: Evidence from a randomised controlled trial
di: Xiaojing Guo, et al.
Pubblicazione: (2026)
di: Xiaojing Guo, et al.
Pubblicazione: (2026)
Documenti analoghi
-
Challenges in glycaemic control among women with type 1 diabetes and the role of MiniMed 780G system: A narrative review
di: Isabeau Thijs, et al.
Pubblicazione: (2026) -
Predictors of glycaemic improvement in children and young adults with type 1 diabetes and very elevated HbA1c using the MiniMed 780G system
di: Yongwen Zhou, et al.
Pubblicazione: (2025) -
Performance of the MiniMed 780 G system on mitigating menstrual cycle‐dependent glycaemic variability
di: Yasmine Ibrahim Elhenawy, et al.
Pubblicazione: (2024) -
Generating real‐world evidence on diabetes technology using the CareLink Personal data management system
di: Tim van den Heuvel, et al.
Pubblicazione: (2024) -
Discordant real‐world glycaemic outcomes with Omnipod™ 5 and MiniMed™ 780G in adults with type 1 diabetes: Why validated measures matter
di: Panagiotis Pavlou, et al.
Pubblicazione: (2026)